News
FDA issues guidance on conducting remote interactive evaluations during the COVID-19 pandemic
15 April 2021
On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring...